P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?

• R Popat,
• A Badros,
• S Kumar,
• P Rodriguez-Otero,
• A Cohen,
• S Manier,
• P Voorhees,
• F Gay,
• R Rifkin,
• T Martin,
• A Chari,
• K Weisel,
• A Farooq,
• B Jeng,
• W Chng,
• H Lee,
• J Berdeja,
• V Jadhav,
• A Tosolini,
• L Eliason,
• A Palumbo,
• M Dimopoulos,
• S Lonial,
• S Trudel,
• P Richardson,
• E Terpos

Affiliations

R Popat

1 University College London Hospitals, NHS Foundation Trust, London (UK)

A Badros

2 University of Maryland School of Medicine, Baltimore (USA)

S Kumar

3 Mayo Clinic, Rochester (USA)

P Rodriguez-Otero

4 Clinica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Navarra (Spain)

A Cohen

5 Perelman School of Medicine, University of Pennsylvania, Philadelphia (USA)

S Manier

6 Lille University Hospital, Lille (France)

P Voorhees

7 Levine Cancer Institute - Atrium Health, Charlotte (USA)

F Gay

8 University of Turin, Turin (Italy)

R Rifkin

9 UC Health, Steamboat Springs (USA)

T Martin

10 University of California San Francisco, San Francisco (USA)

A Chari

11 Mount Sinai, New York (USA)

K Weisel

12 University Medical Center of Hamburg-Eppendorf, Hamburg (Germany)

A Farooq

13 University of Chicago Medical Center, Chicago (USA)

B Jeng

2 University of Maryland School of Medicine, Baltimore (USA)

W Chng

14 National University Cancer Institute of Singapore, Singapore

H Lee

15 The University of Texas MD Anderson Cancer Center, Houston (USA)

J Berdeja

16 Sarah Cannon Research Institute, Nashville (USA)

V Jadhav

17 GlaxoSmithKline, Bengaluru (India), 17*Upper Providence (USA), 17†Zug (Switzerland)

A Tosolini

17 GlaxoSmithKline, Bengaluru (India), 17*Upper Providence (USA), 17†Zug (Switzerland)

L Eliason

17 GlaxoSmithKline, Bengaluru (India), 17*Upper Providence (USA), 17†Zug (Switzerland)

A Palumbo

17 GlaxoSmithKline, Bengaluru (India), 17*Upper Providence (USA), 17†Zug (Switzerland)

M Dimopoulos

18 National and Kapodistrian University of Athens School of Medicine, Athens (Greece)

S Lonial

19 Winship Cancer Institute of Emory University, Atlanta (USA)

S Trudel

20 Princess Margaret Cancer Centre, Toronto (Canada)

P Richardson

21 Dana-Farber Cancer Institute, Boston (USA)

E Terpos

18 National and Kapodistrian University of Athens School of Medicine, Athens (Greece)